PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UCB SA (UCB.BR)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

BE0003739530

Sector

Healthcare

Highlights

Market Cap

€34.15B

EPS (TTM)

€1.22

PE Ratio

147.54

PEG Ratio

1.19

Total Revenue (TTM)

€2.79B

Gross Profit (TTM)

€1.94B

EBITDA (TTM)

€644.00M

Year Range

€94.75 - €198.95

Target Price

€202.88

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of €10,000 in UCB SA, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
11.11%
16.21%
UCB.BR (UCB SA)
Benchmark (^GSPC)

Returns By Period

UCB SA had a return of -6.61% year-to-date (YTD) and 92.01% in the last 12 months. Over the past 10 years, UCB SA had an annualized return of 11.22%, which was very close to the S&P 500 benchmark's annualized return of 11.26%.


UCB.BR

YTD

-6.61%

1M

-1.91%

6M

11.11%

1Y

92.01%

5Y*

15.17%

10Y*

11.22%

^GSPC (Benchmark)

YTD

4.01%

1M

1.13%

6M

9.82%

1Y

22.80%

5Y*

12.93%

10Y*

11.26%

*Annualized

Monthly Returns

The table below presents the monthly returns of UCB.BR, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-2.08%-6.61%
202410.65%21.99%7.42%9.71%3.29%7.81%11.50%5.85%-1.04%9.14%4.84%3.70%145.47%
20232.47%7.96%1.30%3.53%-3.44%-0.39%-0.84%2.83%-6.35%-10.94%-1.77%16.30%8.44%
2022-12.29%11.00%11.00%0.78%-24.21%-1.85%-5.38%-8.13%1.46%7.31%0.60%-4.19%-26.09%
20211.23%-3.60%-1.60%-3.90%-0.70%15.21%3.45%6.23%-0.08%6.51%-6.75%4.38%20.17%
202017.18%0.58%-5.46%5.75%8.88%14.56%5.58%-8.57%-2.53%-12.68%5.74%-5.67%20.43%
20196.09%-2.59%3.91%-6.50%-3.17%6.48%-3.15%-3.79%-1.97%8.50%1.80%-3.62%0.65%
20186.07%-3.02%-2.79%-3.86%7.55%-0.24%9.09%7.21%-1.73%-4.16%0.08%-3.96%9.22%
20174.61%5.48%8.18%-0.49%-12.21%-4.12%2.21%-5.96%4.04%3.75%0.40%5.48%9.85%
2016-5.54%-12.92%-1.78%-1.64%-0.61%3.46%4.12%5.20%-6.49%-10.37%-1.60%0.35%-25.94%
20159.13%-0.90%-1.46%-4.50%2.50%-1.09%9.43%-4.14%3.42%12.70%7.37%-1.53%33.36%
2014-3.05%10.78%-0.05%3.03%-1.03%5.73%11.01%7.37%-2.47%-10.42%-2.03%0.19%18.29%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 98, UCB.BR is among the top 2% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of UCB.BR is 9898
Overall Rank
The Sharpe Ratio Rank of UCB.BR is 9898
Sharpe Ratio Rank
The Sortino Ratio Rank of UCB.BR is 9797
Sortino Ratio Rank
The Omega Ratio Rank of UCB.BR is 9696
Omega Ratio Rank
The Calmar Ratio Rank of UCB.BR is 9999
Calmar Ratio Rank
The Martin Ratio Rank of UCB.BR is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for UCB SA (UCB.BR) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for UCB.BR, currently valued at 3.44, compared to the broader market-2.000.002.003.441.74
The chart of Sortino ratio for UCB.BR, currently valued at 4.17, compared to the broader market-4.00-2.000.002.004.006.004.172.36
The chart of Omega ratio for UCB.BR, currently valued at 1.55, compared to the broader market0.501.001.502.001.551.32
The chart of Calmar ratio for UCB.BR, currently valued at 5.99, compared to the broader market0.002.004.006.005.992.62
The chart of Martin ratio for UCB.BR, currently valued at 30.64, compared to the broader market-10.000.0010.0020.0030.0030.6410.69
UCB.BR
^GSPC

The current UCB SA Sharpe ratio is 3.44. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of UCB SA with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio1.002.003.004.005.006.007.00SeptemberOctoberNovemberDecember2025February
3.44
1.89
UCB.BR (UCB SA)
Benchmark (^GSPC)

Dividends

Dividend History

UCB SA provided a 0.53% dividend yield over the last twelve months, with an annual payout of €0.95 per share. The company has been increasing its dividends for 20 consecutive years.


0.60%0.80%1.00%1.20%1.40%€0.00€0.20€0.40€0.60€0.80€1.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend€0.95€0.95€0.93€0.91€0.89€0.87€0.85€0.83€0.81€0.80€0.80€0.78

Dividend yield

0.53%0.50%1.18%1.24%0.89%1.03%1.19%1.16%1.22%1.32%0.96%1.23%

Monthly Dividends

The table displays the monthly dividend distributions for UCB SA. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025€0.00€0.00€0.00
2024€0.00€0.00€0.00€0.95€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.95
2023€0.00€0.00€0.00€0.93€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.93
2022€0.00€0.00€0.00€0.91€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.91
2021€0.00€0.00€0.00€0.89€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.89
2020€0.00€0.00€0.00€0.00€0.87€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.87
2019€0.00€0.00€0.00€0.85€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.85
2018€0.00€0.00€0.00€0.83€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.83
2017€0.00€0.00€0.00€0.81€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.81
2016€0.00€0.00€0.00€0.80€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.80
2015€0.00€0.00€0.00€0.00€0.80€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.80
2014€0.78€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.00€0.78

Dividend Yield & Payout


Dividend Yield
200.0%400.0%600.0%0.5%
UCB SA has a dividend yield of 0.53%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%111.5%
UCB SA has a payout ratio of 111.48%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-10.00%-8.00%-6.00%-4.00%-2.00%0.00%SeptemberOctoberNovemberDecember2025February
-8.79%
-1.18%
UCB.BR (UCB SA)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the UCB SA. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the UCB SA was 66.75%, occurring on Oct 27, 2008. Recovery took 1117 trading sessions.

The current UCB SA drawdown is 8.79%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-66.75%Dec 18, 2006474Oct 27, 20081117Mar 5, 20131591
-61.84%Aug 5, 19981162Mar 7, 2003898Sep 5, 20062060
-42.14%Apr 19, 2022405Nov 10, 202392Mar 22, 2024497
-34.06%Dec 30, 2015246Dec 12, 2016793Jan 22, 20201039
-33.18%Feb 21, 202022Mar 23, 202057Jun 15, 202079

Volatility

Volatility Chart

The current UCB SA volatility is 6.60%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%SeptemberOctoberNovemberDecember2025February
6.60%
3.50%
UCB.BR (UCB SA)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of UCB SA over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of UCB SA compared to its peers in the Biotechnology industry.


PE Ratio
100.0200.0300.0400.0500.0600.0147.5
The chart displays the price to earnings (P/E) ratio for UCB.BR in comparison to other companies of the Biotechnology industry. Currently, UCB.BR has a PE value of 147.5. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.
PEG Ratio
-1,000.0-800.0-600.0-400.0-200.00.01.2
The chart displays the price to earnings to growth (PEG) ratio for UCB.BR in comparison to other companies of the Biotechnology industry. Currently, UCB.BR has a PEG value of 1.2. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for UCB SA.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab